CYTOTOXIC AND MORPHOLOGICAL EFFECTS OF PHENYLPROPANOLAMINE, CAFFEINE, NICOTINE, AND SOME OF THEIR METABOLITES STUDIED INVITRO

被引:22
作者
BABICH, H [1 ]
BORENFREUND, E [1 ]
机构
[1] ROCKEFELLER UNIV,LAB ANIM RES CTR,NEW YORK,NY 10021
关键词
D O I
10.1016/0887-2333(92)90060-5
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The neutral red cytotoxicity assay was used in vitro to evaluate the potencies of phenylpropanolamine (PPA), nicotine, caffeine, some of their metabolites, and related chemicals. The human cell types used as targets included fibroblast (HFF), melanoma (SK-Mel/27), and hepatoma (HepG2) cell lines and early passage endothelial (ENDO) cells and keratinocytes (NHEK). For all of these cells, nicotine was more cytotoxic than cotinine, its major metabolite; in turn, cotinine was more cytotoxic than chemically related compounds such as nicotinic acid and nicotinamide, Nicotine, but neither cotinine, nicotinic acid, nor nicotinamide, induced cytoplasmic vacuolization in all the cell types tested. Except for the ENDO cells, caffeine and its metabolite, theophylline, showed approximately equivalent cytotoxic potencies. However, for the ENDO cells, caffeine was more cytotoxic than theophylline. Furthermore, the ENDO cells were 2-3 times more sensitive to caffeine and theophylline than were the other cell types. The HFF, SK-Mel/27, and HepG2 cells were more sensitive than the ENDO and NHEK cells to PPA. Phenylpropanolamine induced cytoplasmic vacuolization only in the ENDO cells, Combinations of caffeine + PPA interacted synergistically in their cytotoxicity towards the HepG2 cells; a similar synergistic interaction was not noted with the ENDO cells.
引用
收藏
页码:493 / &
相关论文
共 23 条
[1]   STRUCTURE ACTIVITY RELATIONSHIP (SAR) MODELS ESTABLISHED INVITRO WITH THE NEUTRAL RED CYTOTOXICITY ASSAY [J].
BABICH, H ;
BORENFREUND, E .
TOXICOLOGY IN VITRO, 1987, 1 (01) :3-9
[2]   POSSIBLE RELATION BETWEEN PKA1 AND LIPID SOLUBILITY AND AMOUNTS EXCRETED IN URINE OF SOME TOBACCO ALKALOIDS GIVEN TO MAN [J].
BECKETT, AH ;
JENNER, P ;
GORROD, JW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1972, 24 (02) :115-&
[3]   COTININE DISPOSITION AND EFFECTS [J].
BENOWITZ, NL ;
KUYT, F ;
JACOB, P ;
JONES, RT ;
OSMAN, AL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (05) :604-611
[4]   SHORT-TERM QUANTITATIVE INVITRO CYTOTOXICITY ASSAY INVOLVING AN S-9 ACTIVATING SYSTEM [J].
BORENFREUND, E ;
PUERNER, JA .
CANCER LETTERS, 1987, 34 (03) :243-248
[5]   TOXICITY DETERMINED INVITRO BY MORPHOLOGICAL ALTERATIONS AND NEUTRAL RED ABSORPTION [J].
BORENFREUND, E ;
PUERNER, JA .
TOXICOLOGY LETTERS, 1985, 24 (2-3) :119-124
[6]  
BORZELLECA JF, 1962, J PHARMACOL EXP THER, V137, P313
[7]  
CHAMSON A, 1980, J SUBMICR CYTOL PATH, V12, P401
[8]  
HANES PJ, 1990, J PERIODONTOL, V62, P147
[9]   PHARMACOLOGY AND SAFETY OF PHENYLPROPANOLAMINE [J].
JOHNSON, DA .
DRUG DEVELOPMENT RESEARCH, 1991, 22 (03) :197-207
[10]   EFFECTS OF NICOTINE ON CELLULAR PROLIFERATION, CELL-CYCLE PHASE DISTRIBUTION, AND MACROMOLECULAR-SYNTHESIS IN HUMAN PROMYELOCYTIC HL-60 LEUKEMIA-CELLS [J].
KONNO, S ;
CHIAO, JW ;
WU, JM .
CANCER LETTERS, 1986, 33 (01) :91-97